Skip to main content

Algernon NeuroScience Engages Netcapital Securities for Planned Regulation A Financing

VANCOUVER, British Columbia, March 06, 2025 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its wholly owned subsidiary Algernon NeuroScience (AGN Neuro), has appointed Netcapital Securities Inc. (“Netcapital Securities”), a FINRA-registered broker-dealer, for its planned Regulation A (Reg A) offering. Netcapital plans to provide broker-dealer and administrative services, excluding underwriting and placement agent services, in connection with this offering. AGN Neuro has filed a Form 1-A with the U.S. Securities and Exchange Commission (SEC), though the offering has not yet been qualified or declared effective by the SEC. AGN Neuro intends to use proceeds from the...

Continue reading

EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

Company to host conference call and webcast on Thursday, March 27th at 8:30am EDT AUSTIN, Texas, March 6, 2025 — EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2024, before the markets open on Thursday, March 27th, 2025. An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer, and François Dietsch, Chief Accounting Officer. Please refer to the information below for conference call dial-in information and webcast registration. Call Details: Date:                Thursday, March 27th Time:                 8:30 am EDT Domestic:        1-800-225-9448 International:    1-203-518-9708 Passcode:        EDAP Webcast:...

Continue reading

Questor Announces Sale of Clean Combustion Solution

CALGARY, Alberta, March 06, 2025 (GLOBE NEWSWIRE) — Questor Technology Inc. (“Questor”, the “Company”), (TSX Venture Exchange: QST) announced today a $0.9 million purchase order to supply a clean combustion solution to manage a variety of railcar vapours at a Caltrax Inc. full-service railcar repair and maintenance facility in Calgary. Questor’s partnership with Caltrax highlights the versatility of Questor’s clean combustion units, used in this application to safely and cleanly combust hydrocarbon vapours in urban settings, such as Calgary. Questor’s ISO 14034-certified clean combustion units are engineered to safely manage rail car vapours through a variety of waste gas compositions, eliminating methane and other harmful pollutants at a 99.99% combustion efficiency. These units meet and exceed the most stringent global emissions...

Continue reading

Conavi Medical Announces Uplisting to OTCQB Venture Market

– Expected to enhance visibility and access to U.S. investors – Trading to commence on March 6, 2025 TORONTO, March 06, 2025 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced that its common shares have been approved for uplisting from the OTC Pink Open Market to the OTCQB Venture Market, with trading set to commence on March 6, 2025. The ticker symbol will remain CNVIF, and no action is needed by shareholders. Trading on the OTCQB is expected to complement the Company’s existing listing on the TSX Venture Exchange. “As we move toward commercial launch of our next-generation...

Continue reading

Autolus Therapeutics to Report Fourth Quarter 2024 Financial Results and Host Conference Call on March 20, 2025

LONDON, March 06, 2025 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announced that it will release its fourth quarter and full year 2024 financial results and operational highlights before open of US markets on Thursday, March 20, 2025. Management will host a conference call and webcast at 8:30 am EDT/12:30 pm GMT to discuss the company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call. A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.  About Autolus...

Continue reading

Xunlei Limited Schedules 2024 Unaudited Fourth Quarter and Fiscal Year Earnings Release on March 13, 2025

SHENZHEN, China, March 06, 2025 (GLOBE NEWSWIRE) — Xunlei Limited (“Xunlei” or the “Company”) (NASDAQ: XNET), a leading technology company providing distributed cloud services in China, today announced that it plans to release its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024 on March 13, 2025 before market open. The earnings press release will be available on the Company’s investor relations page at http://ir.xunlei.com. Conference Call Xunlei’s management will host a conference call at 8:00 a.m. U.S. Eastern Time on March 13, 2025 (8:00 p.m. Beijing/Hong Kong Time), to discuss the Company’s quarterly and fiscal year results and recent business developments. Conference Call Preregistration Participant Online Registration: https://register.vevent.com/register/BI571290b28e04470f8c18382c10e6680e Please...

Continue reading

Rego Payment Architectures, Inc. Announces Its White-Label Senior Financial Management Product To Be Available End of March 2025

Financial institutions will be able to launch banking products in their own brand that provide oversight and insight into elderly financial health to their caretakers BLUE BELL, Pa., March 06, 2025 (GLOBE NEWSWIRE) — Rego Payment Architectures, Inc. (“REGO”) (OTCQB: RPMT), the leading white-label family financial lifecycle solution platform, today announced the upcoming launch of a first-of-its-kind white-labeled senior financial management (SFM) product that enables banks and credit unions to help protect the financial well-being of senior citizens. REGO’s SFM product allows financial institutions to deploy an integrated branded solution that provides caretakers and fiduciaries with critical oversight and insight into their loved ones’ financial activity and help guard against fraud – even if they bank at different institutions. Financial...

Continue reading

HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements

MIRAMAR, Fla., March 06, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (Nasdaq: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported that, on March 3, 2025, the Nasdaq Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq” or the “Exchange”) granted the Company an extension in which to regain compliance with all continued listing rules of The Nasdaq Capital Market. The Panel’s determination follows a hearing on February 13, 2025, at which the Panel considered the Company’s plan to regain compliance with Listing Rules 5450(a)(1), 5450(b)(2)(A) and 5450(b)(2&3)(C), the minimum bid price (“Bid Price”), the market value...

Continue reading

IREN February 2025 Monthly Update

SYDNEY, March 06, 2025 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”), today published its monthly update for February 2025. February HighlightsResilient mining hardware profit margin (70%) Ramping up to 50 EH/s over the next 4 months AI Cloud Service nearing full utilization at end of Feb AI Data Center ‘Horizon 1’ customer diligence ongoing Commenced site-works at 1.4GW Sweetwater 1 project, on-track for energization in Apr 2026 Finalizing 600MW Sweetwater 2 connection agreementKey Metrics Feb 25* Jan 25 Dec 24Bitcoin Mining      Average operating hashrate 28.7 EH/s 29.0 EH/s 28.1 EH/sBitcoin mined3 459 BTC 521 BTC 529 BTCRevenue (per Bitcoin) $95,570 $99,789 $98,524Electricity cost (per Bitcoin)1 ($28,341) ($24,683) ($22,799)Revenue $43.9m $52.0m $52.1mElectricity...

Continue reading

GFG Signs Exploration Agreement with Apitipi Anicinapek Nation

SASKATOON, Saskatchewan, March 06, 2025 (GLOBE NEWSWIRE) — GFG Resources Inc. (TSXV: GFG) (OTCQB: GFGSF) (“GFG” or the “Company”) is pleased to announce that it has entered into an Exploration Agreement (“EA”) with Apitipi Anicinapek Nation (“AAN”) with respect to the Company’s Goldarm Property (“Goldarm” or the “Project”) located in the world-class Timmins Gold District of Ontario, Canada. The EA sets the stage for continuous consultation with AAN, providing the community with the chance to engage in the Project through employment, training, and business growth opportunities. As outlined in the EA, GFG will allocate contributions to a community fund based on its exploration expenses in AAN territory. Furthermore, within 10 business days of TSXV approval, the Company will issue $20,000 in GFG common shares to AAN. GFG will calculate...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.